STONY BROOK, N.Y., April 25, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced the award of a contract from HDT Bio for the purpose of rapid, next-generation vaccine development under a ‘Project NextGen: Enabler’ award to HDT Bio (the “Project”). The Project seeks [...]
STONY BROOK, N.Y. – January 5, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced the publication of a peer-reviewed research article in Molecular Therapy – Methods & Clinical Development. The study, titled ‘A linear DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain elicits [...]
By Ken Schachter | September 2, 2021 A Stony Brook company whose human COVID-19 vaccine was repurposed to treat cats has pivoted to a more promising animal market: mink farms. Applied DNA Sciences Inc. expects to begin the new animal trials in upstate Brewster this month, a company spokesman said. Mink, however, will [...]